Published in Methods Enzymol on January 01, 1988
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest (1995) 1.43
Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J Biol Chem (2011) 1.18
A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis. J Interferon Cytokine Res (2011) 1.12
Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice. Arthritis Res (2002) 1.10
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. J Immunol (2009) 1.09
Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study. Arthritis Res Ther (2004) 1.05
Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest (1997) 1.03
Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model. Arthritis Rheum (2009) 0.93
Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci U S A (1999) 0.90
IgG glycosylation in autoimmune-prone strains of mice. Clin Exp Immunol (1994) 0.89
Identification of collagen-induced arthritis loci in aged multiparous female mice. Arthritis Res Ther (2006) 0.87
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols. Arthritis Res Ther (2003) 0.84
Enhancing the inhibitory effect of nicotinamide upon collagen II induced arthritis in mice using N-acetylcysteine. Inflammation (1999) 0.82
Mangiferin suppresses CIA by suppressing the expression of TNF-α, IL-6, IL-1β, and RANKL through inhibiting the activation of NF-κB and ERK1/2. Am J Transl Res (2015) 0.81
Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. ScientificWorldJournal (2013) 0.78
Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis (1995) 0.78
Influence of long term silicone implantation on type II collagen induced arthritis in mice. Ann Rheum Dis (1999) 0.77
Increased susceptibility to collagen-induced arthritis in female mice carrying congenic Cia40/Pregq2 fragments. Arthritis Res Ther (2008) 0.77
Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med (1980) 2.52
B lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis. Ann Rheum Dis (1977) 1.65
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol (1985) 1.53
Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum (1984) 1.52
Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc (1984) 1.37
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.29
IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis (2003) 1.19
Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol (2000) 1.15
Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther (2004) 1.08
Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol (1985) 1.04
Collagen arthritis--what can it teach us? Br J Rheumatol (1994) 0.98
TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis. Ann Rheum Dis (2003) 0.95
IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res (2002) 0.94
Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: a preliminary report. Ann Rheum Dis (2000) 0.94
Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93
Studies of lymphocytes in rheumatoid arthritis. I. Uptake of 125I-heat aggregated human IgG by Fc-receptor bearing lymphocytes. Ann Rheum Dis (1978) 0.92
Cell-based osteoprotegerin therapy for debris-induced aseptic prosthetic loosening on a murine model. Gene Ther (2010) 0.90
Experimental acute hematogenous osteomyelitis in mice. II. Influence of Staphylococcus aureus infection on T-cell immunity. J Orthop Res (1999) 0.87
A novel murine model of orthopaedic wear-debris associated osteolysis. Scand J Rheumatol (2004) 0.87
Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. Am J Reprod Immunol Microbiol (1986) 0.86
Pristane induced arthritis in mice. IV. Immunotherapy with monoclonal antibodies directed against lymphocyte subsets. J Rheumatol (1992) 0.86
Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. Gene Ther (2012) 0.85
Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens (1984) 0.85
Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch. Inflammation (2001) 0.84
Murine type II collagen arthritis. Association of an acute-phase response with clinical course. Arthritis Rheum (1986) 0.83
Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice. Ann Rheum Dis (2005) 0.83
Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigens. Ann Rheum Dis (1981) 0.82
T cell receptor (V beta) bias in the response of rheumatoid arthritis synovial fluid T cells to connective tissue antigens. Scand J Rheumatol (1997) 0.81
Increased dermal elastic fibers in the tight skin mouse. Clin Exp Rheumatol (2004) 0.79
The influence of silicone implantation on type II collagen-induced arthritis in mice. Arthritis Rheum (1997) 0.79
Pristane induced arthritis. II. Genetic regulation in F1 hybrid mice and cellular immune abnormalities following pristane injection. Autoimmunity (1991) 0.79
Total joint arthroplasty and the immune response. Semin Arthritis Rheum (1997) 0.78
Cellular proliferation and cytokine responses to polymethylmethacrylate particles in patients with a cemented total joint arthroplasty. Inflamm Res (1995) 0.78
Crossreactivity as a factor in the immune response to Salmonella typhimurium in CBA and BALB/C mice. J Med Microbiol (1980) 0.78
The influence of silicone implantation on murine lupus in MRL lpr/lpr mice. J Rheumatol (1999) 0.77
A monoclonal anti-type II collagen antibody with cross-reactive anti-Ig activity specific for the F(ab')2 fragment. J Immunol (1988) 0.77
Influence of long term silicone implantation on type II collagen induced arthritis in mice. Ann Rheum Dis (1999) 0.77
Experimental acute hematogenous osteomyelitis in mice. I. Histopathological and immunological findings. J Orthop Res (1999) 0.77
Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. Proc Soc Exp Biol Med (1988) 0.77
Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis. Clin Exp Immunol (2015) 0.75
Identification of new collagen formation with 125I-labeled antibody in bovine pericardial tissue valves implanted in calves. Int J Rad Appl Instrum B (1986) 0.75
The immunoregulation of rheumatoid factor by the CD8 T lymphocyte subset in rheumatoid arthritis. J Rheumatol (1992) 0.75
HLA antigens in rheumatoid arthritis. Agents Actions Suppl (1980) 0.75